PMID: 6164359Jun 1, 1981Paper

Interferon therapy in juvenile laryngeal papillomatosis

Archives of Otolaryngology
S HaglundH Strander

Abstract

Seven cases of severe juvenile laryngeal papillomatosis were treated with exogenous leukocyte interferon (IFN-alpha). Tumor progression occurred in all cases before treatment. During treatment, the tumors decreased in size. When treatment was discontinued (five cases), tumor growth recurred, and after restarting therapy, the tumors once more decreased in size. In one case, the tumor completely vanished. In another case with extensive papillomatosis that extended up to the base of the tongue, a tracheostomy could be closed with only a thin mass of papillomatous tissue that remained on the vocal cords. Exogenous leukocyte interferon therapy can affect the clinical course of juvenile laryngeal papillomatosis. The optimal schedule for therapy has yet to be determined.

Citations

Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·L P TurekP M Howley
Oct 1, 1987·Atherosclerosis·I B RosenzweigE S Shrago
Jan 1, 1997·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·L M AaltonenH Rihkanen
Apr 1, 1986·The Journal of Laryngology and Otology·B C IrwinJ N Evans
Mar 1, 1983·European Journal of Pediatrics·S Levin
Mar 1, 1996·Cancer Metastasis Reviews·B M Steinberg, T P DiLorenzo
Jan 1, 1986·Cancer Metastasis Reviews·P K WeckJ K Whisnant
Aug 1, 1984·European Journal of Clinical Microbiology·P G Higgins
Dec 1, 1985·Antiviral Research·D S Freestone
Jul 1, 1994·Antiviral Research·J D GangemiJ W Kreider
Mar 1, 1995·Acta Oto-laryngologica·J ElöA Bajtai
Jan 1, 1984·Critical Reviews in Clinical Laboratory Sciences·W J Richtsmeier
Aug 2, 2002·Expert Opinion on Pharmacotherapy·David W Kimberlin
Aug 2, 2002·Expert Opinion on Investigational Drugs·Christine Armbruster
Aug 1, 1984·Journal of the American Academy of Dermatology·E J AndrophyD R Lowy
Jan 1, 1988·Journal of the American Academy of Dermatology·Y J Bryson
Aug 9, 2007·Cytokine & Growth Factor Reviews·Hans Strander
Jun 21, 2007·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Alfons Billiau
Feb 14, 2006·Otolaryngologic Clinics of North America·Jennifer G Andrus, Stanley M Shapshay
Oct 1, 1985·Clinics in Dermatology·B M Steinberg, A L Abramson
Oct 1, 1985·Clinics in Dermatology·C Blanchet-Bardon, M A Lutzner
Jul 1, 1988·British Journal of Urology·G Querci della RovereJ E Castro
Jun 1, 2005·Pediatric Clinics of North America·David W Kimberlin
Jan 19, 2000·Otolaryngologic Clinics of North America·G E GreenR J Smith
Nov 15, 1984·The New England Journal of Medicine·T C Merigan
May 26, 1983·The New England Journal of Medicine·B M SteinbergA L Abramson
Jun 1, 1986·International Journal of Dermatology·Q S Ringenberg, P C Anderson
Dec 1, 2007·Nature Reviews. Drug Discovery·Ernest C BordenGeorge R Stark
Sep 1, 1996·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·R García-MiliánS E Perea
Jul 2, 2002·The Annals of Otology, Rhinology, and Laryngology·Ramon A FrancoR Rox Anderson
Sep 1, 1984·The Annals of Otology, Rhinology, and Laryngology·H B NaimanA S Kadish
Jan 1, 1983·The Annals of Otology, Rhinology, and Laryngology·B F McCabe, K F Clark
Apr 1, 1994·The Annals of Otology, Rhinology, and Laryngology·D R EndresR J Smith
Sep 1, 1987·The Annals of Otology, Rhinology, and Laryngology·D M CrockettJ H Mixon
Jul 1, 1982·The Annals of Otology, Rhinology, and Laryngology·H H Dedo, R K Jackler
Jul 1, 1982·The Annals of Otology, Rhinology, and Laryngology·H GoepfertM Sulek
Sep 1, 1983·The Annals of Otology, Rhinology, and Laryngology·R B SessionsJ U Gutterman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.